Five things to know:
1. The company is granting initial buyers a 13-day option to purchase up to an additional $50 million in notes.
2. Interest will be paid in arrears every six months, beginning Dec. 1, 2020. The notes will mature June 1, 2023, unless earlier repurchased or converted.
3. NuVasive plans to initiate privately negotiated convertible note hedge transactions and warrant transactions with one or more dealers.
4. The company aims to use a portion of the net proceeds to pay the cost of the convertible note hedge transactions. The remainder will be used for working capital and other corporate purposes, including mergers and acquisitions, refinancing indebtedness and repurchasing outstanding convertible senior notes due 2021.
5. Price, yield and terms of the notes have yet to be decided.
More articles on devices:
Cleveland Clinic neurosurgeon joins Centerline Biomedical advisory board
Some spine surgeons wouldn’t disclose if they had COVID-19, study says
Which physicians have the most claims denied, resubmitted? A specialty breakdown
